Home / Rupatadine / Czechia
CZ ATC R06AX28 · updated 2 Nov 2026
Rupatadine shortage in Czechia
Is there a Rupatadine shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Rupatadine product is reported short in Czechia, the first since 9 Aug 2026. The company estimate for the return is 28 Sep 2028. Main reason: commercial decision or withdrawal.
Also short in Canada, Italy. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | TAMALIS 10MG 10MG TBL NOB 30 | NOUCOR HEALTH, S.A., Palau-solita i Plegamans | 9 Aug 2026 | 28 Sep 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.